- Home
- FJET vs NERV Comparison
FJET vs NERV Comparison
Compare FJET & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FJET | NERV |
|---|---|---|
| Founded | 2022 | 2007 |
| Country | United States | United States |
| Employees | N/A | 8 |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.1M | 269.6M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | FJET | NERV |
|---|---|---|
| Price | $6.27 | $6.60 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.6M | 103.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 104.12 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,175,600.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.51 | $1.15 |
| 52 Week High | $28.56 | $12.46 |
Technical Indicators
Market Signals| Indicator | FJET | NERV |
|---|---|---|
| Relative Strength Index (RSI) | 37.13 | 71.88 |
| Support Level | $4.66 | $5.66 |
| Resistance Level | $11.72 | $6.69 |
| Average True Range (ATR) | 1.32 | 0.56 |
| MACD | 0.38 | -0.00 |
| Stochastic Oscillator | 23.67 | 93.69 |
Price Performance
Historical ComparisonAbout FJET Starfighters Space Inc. Common Stock
Starfighters Space Inc is a commercial aerospace company based at NASA's Kennedy Space Center in Florida. The company operates supersonic aircraft capable of sustained Mach 2 flight and configured to carry payloads to high altitudes for air launch to space. Its activities include air launch operations, pilot and space flight training, support research, hypersonic testing, and other aerospace development programs. The company provides commercial space services and related aerospace capabilities.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.